Mallory Bernstein

719 Umbilo Road
Durban, ZN 4001, South Africa

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Evolution and viral properties of the SARS-CoV-2 BA.3.2 subvariant.

Evolution and viral properties of the SARS-CoV-2 BA.3.2 subvariant.

Journal: Virus evolution
Published: January 14, 2026

Cerebrospinal Fluid Proteomics Reveals Inflammatory Activation in Aneurysmal Subarachnoid Hemorrhage Irrespective of HIV Status.

Cerebrospinal Fluid Proteomics Reveals Inflammatory Activation in Aneurysmal Subarachnoid Hemorrhage Irrespective of HIV Status.

Journal: medRxiv : the preprint server for health sciences
Published: November 19, 2025

Cerebrospinal fluid proteomics reveals inflammatory activation in aneurysmal subarachnoid hemorrhage irrespective of HIV status.

Cerebrospinal fluid proteomics reveals inflammatory activation in aneurysmal subarachnoid hemorrhage irrespective of HIV status.

Journal: AIDS (London, England)
Published: October 03, 2025

Host proteins associated with strong neutralizing SARS-CoV-2 antibody responses in a South African cohort.

Host proteins associated with strong neutralizing SARS-CoV-2 antibody responses in a South African cohort.

Journal: Communications medicine
Published: August 27, 2024

Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.

Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.

Journal: PLOS global public health
Published: December 04, 2023

Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.

Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.

Journal: medRxiv : the preprint server for health sciences
Published: December 04, 2023

Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant.

Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant.

Journal: Nature communications
Published: September 08, 2023

Clearance of persistent SARS-CoV-2 associates with increased neutralizing antibodies in advanced HIV disease post-ART initiation.

Clearance of persistent SARS-CoV-2 associates with increased neutralizing antibodies in advanced HIV disease post-ART initiation.

Journal: Nature communications
Published: August 10, 2023

SARS-CoV-2 infection in immunosuppression evolves sub-lineages which independently accumulate neutralization escape mutations.

SARS-CoV-2 infection in immunosuppression evolves sub-lineages which independently accumulate neutralization escape mutations.

Journal: Virus evolution
Published: May 02, 2023

Metformin Increases Cell Viability and Regulates Pro-Inflammatory Response to Mtb.

Metformin Increases Cell Viability and Regulates Pro-Inflammatory Response to Mtb.

Journal: Infection and drug resistance
Published: December 13, 2022

SARS-CoV-2 evolves increased infection elicited cell death and fusion in an immunosuppressed individual.

SARS-CoV-2 evolves increased infection elicited cell death and fusion in an immunosuppressed individual.

Journal: medRxiv : the preprint server for health sciences
Published: December 01, 2022

Author Correction: Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection.

Author Correction: Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection.

Journal: Nature communications
Published: October 13, 2022
Showing 1-12 of 27

Last Updated: 09/26/2026